Shin Poong Pharmaceutical Co. Ltd.

Quick facts

Marketed products

• Pyramax · Other

Phase 3 pipeline

• SP-8203 · Diabetes
  SP-8203 is a small molecule that targets the SGLT2 receptor.
• SP5M001 inj · Diabetes
  SP5M001 inj is a small molecule drug that targets the SGLT2 receptor.
• Synovian inj · Rheumatology; Orthopedics
  Synovian is a hyaluronic acid-based intra-articular injection that lubricates and cushions joint cartilage to reduce pain and improve mobility in osteoarthritis.

Phase 2 pipeline

• Favipiravir plus Nitazoxanide
• SP-8203 High dose
• SP-8203 Low dose
• SPC 1001 Mid2
• SPC 2002
• SPC 2003
• SPC 2004
• SPC1001 High
• SPC1001 Low
• SPC1001 Mid1
• SPC1001 Mid2
• SPC3001
• SPC4001
• SPC4002
• SPC5002
• SPC5003
• SPC5004

Phase 1 pipeline

• SP-8008 Prototype Capsule A
• SP-8008 Prototype Capsule B

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Shin Poong Pharmaceutical Co. Ltd. portfolio CI brief
• Shin Poong Pharmaceutical Co. Ltd. pipeline updates RSS